戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 st commonly in the brain, on the neural cell adhesion molecule.
2 king adhesion mediated by the L1 neural cell adhesion molecule.
3 e-bound surface receptor, soluble ligand, or adhesion molecule.
4 dependent growth, are both dependent on cell adhesion molecules.
5  an extracellular substrate through specific adhesion molecules.
6 ructural stabilization of spines by synaptic adhesion molecules.
7  interaction with postsynaptic receptors and adhesion molecules.
8 ols hepatic metastasis via modulation of HEC adhesion molecules.
9 rans-heterophilic interaction with mDA-bound adhesion molecules.
10 ribe recent therapeutic approaches targeting adhesion molecules.
11 ic nanomachines that are aligned by synaptic adhesion molecules.
12 ted by specific interactions between surface adhesion molecules.
13  produce less pro-inflammatory cytokines and adhesion molecules.
14  alpha (TNF-alpha) by reducing expression of adhesion molecules.
15 production of pro-inflammatory cytokines and adhesion molecules.
16 avenously injected antibody to vascular cell adhesion molecule 1 (anti-VCAM) in the inflamed brain is
17 showed that carcinoembryonic Ag-related cell adhesion molecule 1 (CEACAM-1), a molecule expressed on
18  the NET-associated carcinoembryonic Ag cell adhesion molecule 1 (CEACAM1) as an essential element fo
19 absent carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) exhibited increased ischem
20 etween carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) expression and malignant p
21  wildtype mice, glycosylation-dependent cell adhesion molecule 1 (Glycam1), expressed 7-fold higher i
22 ntial expression of VCAM-1 and intercellular adhesion molecule 1 (ICAM-1) was regulated by the spatio
23            Surprisingly, while intercellular adhesion molecule 1 (ICAM-1) was significantly upregulat
24 gly, the genetic deficiency of intercellular adhesion molecule 1 (ICAM-1), an established ligand of M
25 ular adhesion protein known as intercellular adhesion molecule 1 (ICAM-1), which helps initiate and s
26 complex and in upregulation of intercellular adhesion molecule 1 (ICAM-1).
27 dies against mucosal vascular addressin cell adhesion molecule 1 (MADCAM1), which is capable of block
28                                  Neural cell adhesion molecule 1 (NCAM1; CD56) is expressed in up to
29 nuous detection of platelet endothelial cell adhesion molecule 1 (PECAM-1)-dependent, outside-in sign
30 flammatory biomarkers [soluble intercellular adhesion molecule 1 (sICAM-1), high sensitivity C-reacti
31  to transferrin receptor-1 and intercellular adhesion molecule 1 (TfR-1 and ICAM-1).
32 o the lungs via RAGE-dependent vascular cell adhesion molecule 1 (VCAM-1) expression on lung endothel
33 y binding of beta1-integrin to vascular cell adhesion molecule 1 (VCAM-1) on neurons in the inflammat
34 uction of the pro-inflammatory vascular cell adhesion molecule 1 (VCAM1) cell-adhesion protein.
35 ile with focal upregulation of vascular cell adhesion molecule 1 (VCAM1), a protein that facilitates
36 he cellular adhesion molecules Intercellular Adhesion Molecule 1 and Vascular Cell Adhesion Molecule
37  rats exhibited a reduction in vascular cell adhesion molecule 1 expression and reduced cytokine-indu
38 lular adhesion molecule 1, and vascular cell adhesion molecule 1 expression; and (e) ELISA for cytoki
39 other rhinoviruses, which bind intercellular adhesion molecule 1 receptors via a capsid protein VP1-s
40 2 and TMPRSS2, and for ICAM-1 (intercellular adhesion molecule 1) (rhinovirus receptor as a comparato
41 , tumor necrosis factor-alpha, intracellular adhesion molecule 1, and MCP-1; P < 0.05), and reduced o
42 NOS, endothelin-1, P-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule
43 ctor alpha, caspase-1 (CASP1), intercellular adhesion molecule 1, IL-10, heme oxygenase 1 hypoxia-ind
44 ived von Willebrand factor and vascular cell adhesion molecule 1, sensitizes DTCs to chemotherapy.
45 llular Adhesion Molecule 1 and Vascular Cell Adhesion Molecule 1, thereby amplifying leukocyte traffi
46  (Flk1, Tal1/Scl1, platelet endothelial cell adhesion molecule 1, vascular endothelial-cadherin, and
47                          ICAM (intercellular adhesion molecule)-1 and PFKFB3 were also found to be up
48 lls had higher levels of ICAM (intercellular adhesion molecule)-1 and TF expression following TNF (tu
49 hesion molecules, particularly intercellular adhesion molecule-1 (ICAM-1) and a subsequent decrease i
50 um on which ligands, including intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion
51                                Intercellular adhesion molecule-1 (ICAM-1) expressing neutrophils prod
52 es cerebral overexpression of Inter-Cellular Adhesion Molecule-1 (ICAM-1) in mice.
53                       Blocking intercellular adhesion molecule-1 (ICAM-1) inhibited the cytolytic res
54                                Intercellular adhesion molecule-1 (ICAM-1) is up-regulated during infl
55 oupled with antibodies against intercellular adhesion molecule-1 (ICAM-1), a glycoprotein overexpress
56        This study investigated intercellular adhesion molecule-1 (ICAM-1), a membrane protein that me
57 ked blast-induced increases in intercellular adhesion molecule-1 (ICAM-1), a molecule that plays a cr
58 nanocarriers (NCs) targeted to intercellular adhesion molecule-1 (ICAM-1), an endothelial-surface gly
59 hesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1), endothelial dysfunction, a
60 t common of these receptors is intracellular adhesion molecule-1 (ICAM-1), which is bound by 2 distin
61  progenitor cells give rise to intercellular adhesion molecule-1 (ICAM1)/CD54-expressing (CD54+) comm
62 ndothelial absence of mucosal addressin cell-adhesion molecule-1 (MAdCAM-1), which was also coupled w
63  follow-up in concentration of intercellular adhesion molecule-1 (P < .001), interleukin-10 (P = .041
64 -toxin (CPB) binds platelet endothelial cell adhesion molecule-1 (PECAM-1) (also known as CD31) to in
65  the expression of platelet endothelial cell adhesion molecule-1 (PECAM-1) and a decrease in the expr
66  the expression of platelet endothelial cell adhesion molecule-1 (PECAM-1) and a decrease in the expr
67                        Soluble intercellular adhesion molecule-1 (sICAM1) was measured in the plasma
68 eatic cancer and found soluble vascular cell adhesion molecule-1 (sVCAM-1) increases in response to g
69 uced endothelial expression of vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion
70                              First, vascular adhesion molecule-1 (VCAM-1) was evaluated as a vascular
71 hesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), are expressed.
72 it on myeloma cells stimulated vascular cell adhesion molecule-1 (VCAM1) on MSCs, leading to the acti
73 0 mmol/L; P = 0.021), and intercellular cell adhesion molecule-1 (WA: 153.9 ng/mL; CB: 159.4 ng/mL; P
74 receptor II [sTNFRII], soluble Intercellular Adhesion Molecule-1 [sICAM-1]), angiogenic (soluble Endo
75 cyte chemotactic protein-1 and intercellular adhesion molecule-1 as model genes.
76 nd IL-10 and reduced CD11b and intercellular adhesion molecule-1 expression on neutrophils, suggestin
77 ial growth factor, and soluble vascular cell adhesion molecule-1 were associated with DFU healing.
78 l adhesion molecule-1, soluble intercellular adhesion molecule-1) and immune (soluble triggering rece
79 r adhesion molecule-1, soluble vascular cell adhesion molecule-1, soluble E-Selectin, and P-Selectin)
80 von Willebrand factor, soluble intercellular adhesion molecule-1, soluble E-Selectin, P-Selectin, and
81 ike tyrosine kinase-1, soluble vascular cell adhesion molecule-1, soluble intercellular adhesion mole
82 active protein, interleukin-6, intercellular adhesion molecule-1, soluble tumor necrosis factor recep
83 -1 and angiopoietin-2, soluble intercellular adhesion molecule-1, soluble vascular cell adhesion mole
84 ts after LIGHT stimulation via intercellular adhesion molecule-1.
85 ll adhesion molecule-1], ICAM [intercellular adhesion molecule-1], and MCP1 [monocyte chemoattractant
86 mmation (p65, caspase 1, VCAM [vascular cell adhesion molecule-1], ICAM [intercellular adhesion molec
87  mouse carcinoembryonic antigen-related cell adhesion molecule 1a (mCEACAM1a) and mediate virus entry
88              JAM2 encodes for the junctional-adhesion-molecule-2, a key tight-junction protein in blo
89 rd the dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin receptor.
90 ectins dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) or DC
91 luding dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN), so t
92  human dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (hCD209a), an H
93 D68 receptors, sialic acid and intracellular adhesion molecule 5 (ICAM-5), in neuronal infection.
94  carcinoembryonic antigen (CEA)-related cell adhesion molecules 5 (CEACAM5) & 1 (CEACAM1) were used f
95 ly coupled to a protein known as multivalent adhesion molecule 7, an adhesin which mediates the initi
96 inal epithelial barrier function, junctional adhesion molecule A knockout mice, F11r(-/-) .
97                            JAM-A (junctional adhesion molecule A) is a transmembrane component of tig
98  of its cellular receptor, feline junctional adhesion molecule A.
99                                   Junctional adhesion molecule-A (JAM-A), an epithelial tight junctio
100 a1 engages sialylated glycans and junctional adhesion molecule-A (JAM-A), triggering uptake into the
101 unrecognized guidance mechanism whereby cell adhesion molecules act in trans to modulate the response
102 ted as 4 independent clusters: interleukins, adhesion molecules, acute-phase proteins, and chemokines
103           Here, we report that that the cell adhesion molecule ALCAM (CD166) can act as an extracellu
104 philin3 are ligands for the presynaptic cell adhesion molecule alpha-neurexin.
105 ta-2 is independent of the prototypical cell-adhesion molecules alpha-neurexins (alpha-Nrxns); howeve
106 populations expressing CD24, epithelial cell adhesion molecule and folate receptor alpha proteins, an
107 ressing the oncogenic target epithelial cell adhesion molecule and identify a panel of three novel bi
108 n the polysialylated form of the neural cell adhesion molecule and in perineuronal nets surrounding p
109 esulting in suppression of tumor endothelial adhesion molecules and activated and effector CD8(+) T c
110 ct interactions are collectively called cell adhesion molecules and are divided into four major group
111 osed of neurotransmitter receptors, synaptic adhesion molecules and downstream signalling effectors.
112 ound a strong positive correlation with cell adhesion molecules and IFN response pathways and a stron
113                          Differences in cell adhesion molecules and leukocyte adhesion were ablated w
114 f cones and illustrate how interplay between adhesion molecules and postsynaptic transmitter receptor
115              Here, we discuss how glial cell adhesion molecules and the extracellular matrix molecule
116            The characterization of leukocyte adhesion molecules and their control by proinflammatory
117 of nutrient transporters, down-regulation of adhesion molecules and tumor suppressing phosphatases, a
118 ic binding with neurexin, a presynaptic cell adhesion molecule, and also binds to PSD-95, although th
119 gans can rely on different organ properties, adhesion molecules, and chemokines.
120  convertase subtilisin/kexin type 9 (PCSK9), adhesion molecules, and clotting and inflammatory factor
121           The pattern of chemokine gradient, adhesion molecules, and cytokine transcripts is highly s
122 posed monocytes exhibit higher expression of adhesion molecules, and higher abilities to attach onto
123 eased HEVs, upregulated chemokines, and cell adhesion molecules, and led to greater numbers of Tregs
124 icroglia, astrocytes, cytokines, chemokines, adhesion molecules, and other inflammatory markers in po
125 ctionalized with anti-EpCAM (epithelial cell adhesion molecule) antibodies to isolate CTCs from human
126                Nectin and nectin-like (Necl) adhesion molecules are broadly overexpressed in a wide r
127 thermore, it is appreciated that endothelial adhesion molecules are heavily N-glycosylated, but beyon
128 (+) T cells, suggesting that factors such as adhesion molecules are necessary for the stabilization o
129                                    Many cell adhesion molecules are present along myelinated axons an
130 factor of the Wnt signaling pathway and cell adhesion molecule, as a CK5 interactor, which we confirm
131 ate differences in chemokines, cytokines, or adhesion molecules associated with monocyte recruitment,
132 evel of alpha5beta1 integrin, the major cell adhesion molecule at the surface of HeLa and MDA-MB-231
133 tracellular trafficking routes of junctional adhesion molecule-C (JAM-C).
134 omote the cytokine-induced inflammatory cell adhesion molecule (CAM) expression including VCAM-1, ICA
135 ivo RNAi screen of PyN-expressed axonal cell adhesion molecules (CAMs) and select Ephs/ephrins.
136     On the other hand, up-regulation of cell adhesion molecules (CAMs) associated genes was only foun
137 anding the dynamical gene regulation of cell adhesion molecules (CAMs) responsible for the emerging s
138 yte-axon contact is mediated by several cell adhesion molecules (CAMs) that are positioned at distinc
139 acts the synthesis of membrane-targeted cell adhesion molecules (CAMs), measured by pulsed stable iso
140 at G protein-coupled receptors (GPCRs), cell adhesion molecules (CAMs), receptor tyrosine kinases (RT
141                  The cadherin superfamily of adhesion molecules carry O-linked mannose glycans at con
142 eased expression of membrane-bound leukocyte adhesion molecule CD11b, leading to enhanced inflammatio
143 vel electrochemical sensor for a neural cell adhesion molecule (CD56) was constructed by glycosyl imp
144 SIGLEC12, as well as the CD2 ligand and cell adhesion molecule CD58, all of which may be involved in
145 immune system, and cancer cells, focusing on adhesion molecule CDH11, which has been associated with
146                     Recent studies implicate adhesion molecule CDHR2 in the regulation of microvillar
147 of the carcinoembryonic antigen-related cell adhesion molecule (CEACAM) family, which interact with m
148 egulate carcinoembryonic antigenrelated cell adhesion molecules (CEACAMs) on the surface of small int
149                                         Cell adhesion molecule close homolog of L1 (CHL1) and the dop
150 s harbor a characteristic energy metabolism, adhesion molecule composition, as well as RNA-processing
151 al effector genes, such as channels and cell adhesion molecules, contribute disproportionately to neu
152 sferase, cytokeratin 19, epithelial cellular adhesion molecule, cystic fibrosis transmembrane conduct
153                         Two interacting cell adhesion molecules, Dpr11 and DIPgamma, are essential fo
154                                         Such adhesion molecule-driven retention of senescent erythroc
155 rotein-1 (Xbp1), (ii) the Down Syndrome Cell Adhesion Molecule (Dscam) gene and iii) the embryonic le
156                       The Down Syndrome Cell Adhesion Molecule (Dscam) gene from Drosophila is one of
157                           Down syndrome cell adhesion molecules (dscam and dscaml1) are essential reg
158  with the epithelial cell-specific cell-cell adhesion molecule E-cadherin in the dental epithelium.
159                                     The cell adhesion molecule E-cadherin is a major component of adh
160  we show that IFs downregulate the cell-cell adhesion molecule E-cadherin on non-tumorigenic cells an
161 obably through a mechanism that involves the adhesion molecule E-cadherin.
162                         The endothelial cell adhesion molecule E-selectin is a key component of the b
163 n HUVEC cells by decreasing endothelial cell adhesion molecule E-Selectin production, (ii) transmigra
164 h a concurrent reduction in endothelial cell adhesion molecule E-selectin, (ii) transmigration throug
165                                Expression of adhesion molecules, ectonucleotidases (CD39 and CD73), t
166 erminals functions in synergy with a related adhesion molecule, ELFN1, and their concerted interplay
167 one-dominant species, we identified the cell-adhesion molecule ELFN2 to be pivotal for the functional
168  the extracellular domain of epithelial cell adhesion molecule (EpCAM) (EpEX) significantly increases
169 an antibody specific for the epithelial cell adhesion molecule (EpCAM) and sorted into four zones of
170                     Although epithelial cell adhesion molecule (EpCAM) has previously been shown to p
171  12 (AKAP12), cytokeratin 7, epithelial cell adhesion molecule (EPCAM), and carbamoyl palmitate synth
172 ce receptors, which included epithelial cell adhesion molecule (EpCAM), carbonic anhydrase IX (CA9),
173 ificity for a model antigen, epithelial cell adhesion molecule (EpCAM), this study demonstrates that
174 nt [K(D)], 2.9 nM) and mouse epithelial cell adhesion molecule (EpCAM; K(D), 21 nM), and with [(89)Zr
175 T cell-associated molecule (CRTAM) is a cell adhesion molecule expressed by intraepithelial T cells a
176 in-155 (Nfasc155) is an essential glial cell adhesion molecule expressed in paranodal septate-like ju
177 ssical cadherins constitute a family of cell adhesion molecules expressed in complex combinatorial pr
178 enhance infection, enveloped viruses exploit adhesion molecules expressed on the surface of host cell
179  cancer cells based on their Epithelial Cell Adhesion Molecule expression (>90%) and detection by the
180 h either MRSA or S. pneumoniae Surprisingly, adhesion molecule expression, antimicrobial peptide prod
181  to decreased endothelial barrier, increased adhesion molecule expression, or Weibel-Palade body rele
182                         Measuring epithelial adhesion molecule expression, we observed that female mi
183 and platelets, as measured by a reduction in adhesion molecule expression.
184  we conditionally deleted all three neurexin adhesion molecules from presynaptic neurons of the calyx
185 s, including defective expression of surface adhesion molecules, generation of superoxide anion, and
186 , L1, a brain derived neuronal specific cell adhesion molecule, has been covalently bound to the neur
187 nd tissue behaviors due to the regulation of adhesion molecules, here we present a novel, to our know
188 m was associated with elevated levels of the adhesion molecules ICAM and VCAM and the pattern-recogni
189 esion molecule (VCAM), but not intercellular adhesion molecule (ICAM), suggesting they are early mese
190                 E-selectin and intercellular adhesion molecule (ICAM)-1 are biomarkers of endothelial
191 icant reduction of circulating intercellular adhesion molecule (ICAM)-1 was observed.
192 udes selected residues from an intercellular adhesion molecule (ICAM)-like motif shared between the S
193           Notably, expression of endothelial adhesion molecule ICAM1 by HEC was significantly reduced
194 identified the immunoglobulin family of cell adhesion molecules (IgCAMs) as direct substrates, with D
195 eratinocytes, and functions as a cell-matrix adhesion molecule in the dermal-epidermal junction of th
196 e, we highlight recently discovered roles of adhesion molecules in collective cancer cell migration a
197 ch as neurodevelopmental processes in BPD or adhesion molecules in COPD, are also highlighted.
198 xpression of intercellular and vascular cell adhesion molecules in EC, an effect that was also HDAC6-
199 ly diminished NETs-dependent upregulation of adhesion molecules in human endothelial cells.
200                                     Multiple adhesion molecules including DYF-7, SAX-7, HMR-1 and DLG
201 es, receptors, immune checkpoint ligands and adhesion molecules, including CSF2, CD40, PD-L1/PD-L2, a
202 s on ALL cell adhesion to the stroma through adhesion molecules, including integrins.
203 synaptically with multitudinous postsynaptic adhesion molecules, including SliTrks, SALMs, and TrkC.
204  as mice with myeloid cells deficient in the adhesion molecule integrin alpha4 were protected from ne
205  leading to an up-regulation of the cellular adhesion molecules Intercellular Adhesion Molecule 1 and
206 s established to date lack expression of key adhesion molecules involved in immune cell migration acr
207 inger's discovery of the first immune system adhesion molecules involved in lymphocyte homing and the
208 d knowledge exists on the relevant cell-cell adhesion molecules involved in physiological epithelial
209                                          The adhesion molecules involved in this so-called T-cell ros
210              Bidirectional signaling by cell adhesion molecules is thought to mediate synapse formati
211  examine how targeting of NF186, a key nodal adhesion molecule, is regulated by the flanking paranoda
212 n interaction occurs between Grasp55 and the adhesion molecule Jam-C, which plays a central role in s
213 vestigations into TJ proteins and junctional adhesion molecules (JAM) in cancer suggested a tumor-sup
214           BP antibodies target two epidermal adhesion molecules, known as BP180 and BP230.
215                                          The adhesion molecule L-selectin has recently been implicate
216             Proteolytic cleavage of the cell adhesion molecule L1 (L1) in brain tissue and in culture
217                     (2019) identify the cell adhesion molecule L1CAM as integral to the mechanism by
218  express a novel isoform of the cell-surface adhesion molecule L1CAM, termed L1-DeltaTM.
219 ethacrylate) coated beads to isolate L1 cell adhesion molecule (L1CAM)-positive extracellular vesicle
220 tion, reduced chemokine receptor (CXCR3) and adhesion molecule (LFA-1) expression by T cells, and dow
221 chanically comparable to previously reported adhesion molecule-ligand interactions.
222                          Lutheran/basal cell adhesion molecule (Lu/BCAM) promotes tumor cell migratio
223                   Vasculature expressing the adhesion molecule MAdCAM-1 clustered near the crypt base
224  recombinant mucosal vascular addressin cell adhesion molecule (MAdCAM-)1 in vitro as well as the eff
225                                 A network of adhesion molecules mediate this physical interaction bet
226 how for the first time that a trans-synaptic adhesion molecule mediates specific interactions at axo-
227                            Since neural cell adhesion molecule (NCAM) activates FGF receptors, we ask
228 le inter-subject accumulation of neural cell adhesion molecule (NCAM)-positive myofibres, and an accu
229                    We identified Neural Cell Adhesion Molecule (NCAM1) as a potential ZIKV receptor a
230 O mice and showed that Kirrel3 is a synaptic adhesion molecule necessary to form one specific type of
231                                The axo-glial adhesion molecules neurofascin155 (NF155) and myelin-ass
232 rved IgCAMs (immunoglobulin superfamily cell adhesion molecules), neuroglian (Nrg) and fasciclin 2 (F
233 he ortholog of CASK, that binds the synaptic adhesion molecule NLG-1/Neuroligin and physically connec
234 n autism-associated mutation in the synaptic adhesion molecule Nlgn3 results in impaired oxytocin sig
235              Many mutations on X-linked cell adhesion molecule NLGN4X result in ASD or intellectual d
236 dentify transcription factors (TFs) and cell-adhesion molecules not previously implicated in NC migra
237 ctions in vivo, which includes neuronal cell adhesion molecule (NRCAM).
238 eir role in the accumulation of NF186, a key adhesion molecule of PNS and CNS nodes.
239 s of Ranvier is mediated by a number of cell adhesion molecules of the immunoglobulin superfamily inc
240 locked the capacity of these cells to induce adhesion molecules on dermal microvascular endothelial c
241 ding snoU1RNA was only capable of increasing adhesion molecules on endothelial cells in the presence
242 tion by preventing leukocyte engagement with adhesion molecules on the endothelial surface.
243 gmentation index, blood glucose, endothelin, adhesion molecules, or clotting factors in this weight-s
244 n the transient production of chemokines and adhesion molecules orchestrating monocyte engraftment.
245    Fucoidan, a polysaccharidic ligand of the adhesion molecule P-selectin, exhibits antiproliferative
246 g in reduced expression of tumor endothelial adhesion molecules, particularly intercellular adhesion
247  in cell surface levels of the intercellular adhesion molecule PECAM-1 (CD31) when examined by flow c
248 ty ligands specific for the endothelial cell adhesion molecules, PECAM-1 (CD31) and ICAM-1 (CD54).
249 h response (EGR3), platelet endothelial cell adhesion molecule (PECAM1) and L-selectin (SELL) were pa
250 rst hiPSC-derived BBB model that displays an adhesion molecule phenotype that is suitable for the stu
251 e conserved IgSF9-family trans-synaptic cell adhesion molecules, plays a novel and specific role in r
252 ies have utility for killing epithelial cell adhesion molecule-positive cells when used as a targetin
253 ne this concept, we cultured epithelial cell adhesion molecule-positive reactive cholangioids (ERCs)
254 rect evidence that BP180, a cell-cell matrix adhesion molecule, possesses antitumor function through
255 NCAM1/2, respectively, Nrg and Fas2 are cell adhesion molecules primarily studied in the context of n
256 onal plasma membrane domains through L1 cell-adhesion molecule protein, where it couples microtubules
257  WPB, leading to the surface presentation of adhesion molecules relevant for leukocyte rolling (P-sel
258 chanisms that govern the removal of specific adhesion molecules remain unclear.
259  (1) there are mechanisms governing specific adhesion molecule remodeling; (2) neuroligin-3 is a key
260           Classical cadherins are well-known adhesion molecules responsible for physically connecting
261  IL-6 levels and downregulated expression of adhesion molecules resulting in impaired leukocyte extra
262 udies have strongly implicated synaptic cell adhesion molecules (sCAMs) in several such disorders tha
263  through elevated expression of inflammatory adhesion molecules such as ICAM1 and CD11b as well as im
264 of numerous protein families, including cell-adhesion molecules, surface receptors, and their ligands
265 urthermore, we identified the conserved cell adhesion molecule SYG-1/Neph as a receptor for the cleav
266   The trans-synaptic interaction of the cell-adhesion molecules teneurins (TENs) with latrophilins (L
267 lso observed with a loss of GlialCAM, a cell adhesion molecule that binds to ClC-2 in glia.
268               MCAM (CD146) is a cell surface adhesion molecule that has been reported to promote canc
269 d proline-rich receptor-1 (IGPR-1) is a cell adhesion molecule that regulates angiogenesis and endoth
270    L-selectin on T-cells is best known as an adhesion molecule that supports recruitment of blood-bor
271  single-pass transmembrane postsynaptic cell adhesion molecules that are important for synapse assemb
272               Neuroligins, postsynaptic cell adhesion molecules that are linked to neuropsychiatric d
273 yeloid leukemia (bcCML) and identify several adhesion molecules that are preferentially expressed in
274 xins are well-characterized presynaptic cell adhesion molecules that engage multifarious postsynaptic
275 scle relied upon the same suite of cell-cell adhesion molecules that functioned in the endogenous nic
276 ine-phosphatases (LAR-RPTPs) are presynaptic adhesion molecules that interact trans-synaptically with
277 ins (NLGNs) are a class of postsynaptic cell adhesion molecules that interact with presynaptic neurex
278                    Neurexins are presynaptic adhesion molecules that organize synapses by binding to
279                 beta2 integrins are critical adhesion molecules that regulate a number of neutrophil
280              Neurexins are presynaptic, cell-adhesion molecules that specify the functional propertie
281                          By binding to these adhesion molecules, the immunoreceptors DNAX accessory m
282 tercellular adhesion molecule, vascular cell adhesion molecule, thrombomodulin) and inflammatory biom
283 tercellular adhesion molecule, vascular cell adhesion molecule, thrombomodulin, endocan, C-reactive p
284 lar endothelial growth factor, vascular cell adhesion molecule, thrombomodulin, endocan, interleukin-
285 ing from extracellular matrix components and adhesion molecules to chemokines and growth factors.
286                             P-selectin is an adhesion molecule translocated to the surface of endothe
287            This study demonstrates that cell adhesion molecule transmembrane and immunoglobulin domai
288 Willebrand factor, E-selectin, intercellular adhesion molecule, vascular cell adhesion molecule, thro
289 Willebrand factor, E-selectin, intercellular adhesion molecule, vascular cell adhesion molecule, thro
290 popolysaccharide (LPS)-induced vascular cell adhesion molecule (VCAM) protein levels by ~50%, whereas
291 in beta receptor (LTbetaR) and vascular cell adhesion molecule (VCAM), but not intercellular adhesion
292 the fact that HuR increased the abundance of adhesion molecule VLA-4 on Th17 cells, knockout of HuR i
293                          Loss of endothelial adhesion molecules was accompanied by increased F-actin
294     Membrane-anchored PrP(C) and neural cell adhesion molecule were not required for S-PrP-initiated
295 ta1 integrin was selective as other synaptic adhesion molecules were unchanged.
296  V), GRN (granulin), and MCAM (melanoma cell adhesion molecule) were associated with PLT, while MPO (
297      In addition, we showed that erythrocyte adhesion molecules, which are specifically activated on
298 ectly to cartilage surfaces via retention of adhesion molecules while maintaining the cell sheets' ch
299 e characterize ELFN2 as a novel postsynaptic adhesion molecule with a distinct expression pattern thr
300  transmembrane (LRRTM) proteins are synaptic adhesion molecules with roles in synapse formation and s

 
Page Top